Philips, Sim&Cure Expand Neurovascular Therapy Partnership

Philips has expanded its strategic partnership with Sim&Cure, a provider of advanced digital solutions for neurovascular therapy.

The partnership between the two began five years ago and now enters its next phase. The aim is to further enhance Philips’ position in interventional neurology by integrating Sim&Size software into Philips’ Azurion image-guided therapy platform. This connection hopes to offer a more seamless, intuitive, and efficient workflow to treat complex brain aneurysms.

By integrating Sim&Size into Azurion, physicians can simulate device placement, optimize selection, and guide deployment directly in the Azurion platform. This removes the need for separate software and hardware setups, allowing more precision and efficiency in neurovascular procedures.

“The strengthened collaboration with Sim&Cure allows us to bring the power of simulation and image-guided therapy together in one platform, enhancing physician confidence and improving patient outcomes,” said Nicole Hermkens, VP Marketing IGT Systems at Philips. “By integrating Sim&Size into our Azurion platform, we are reducing complexity and variability in neurovascular procedures, ultimately helping to address the growing burden of brain aneurysms.”

Earlier this year, Philips introduced the latest version of Azurion, a biplane model designed specifically to support neuro interventions. It features enhanced 2D and 3D imaging capabilities, improved C-arm rotation flexibility, and optimized workflow features.

“We are excited to deepen our relationship with Philips and expand our joint impact in neurovascular therapy,” said Mathieu Sanchez, CEO of Sim&Cure. “Our combined offering allows clinicians to confidently plan and execute minimally invasive treatments, bringing the best of both companies’ innovations to bear for improved patient care.”